| Primary |
| Hormone Replacement Therapy |
85.3% |
| Menopausal Symptoms |
3.6% |
| Menopause |
2.9% |
| Hypertension |
2.1% |
| Blood Pressure |
0.6% |
| Thyroid Disorder |
0.6% |
| Depression |
0.6% |
| Hypothyroidism |
0.5% |
| Anxiety |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Osteoporosis |
0.3% |
| Arthritis |
0.3% |
| Diabetes Mellitus |
0.3% |
| Hot Flush |
0.3% |
| Cardiac Disorder |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Asthma |
0.3% |
| Pain |
0.3% |
| Hypersensitivity |
0.2% |
| Blood Cholesterol |
0.2% |
|
| Breast Cancer Female |
68.8% |
| Breast Cancer |
20.7% |
| Progesterone Receptor Assay Positive |
2.2% |
| Ovarian Cancer |
1.8% |
| Breast Cancer In Situ |
1.4% |
| Breast Cancer Metastatic |
0.9% |
| Cerebrovascular Accident |
0.7% |
| Thrombosis |
0.6% |
| Deep Vein Thrombosis |
0.5% |
| Pulmonary Embolism |
0.5% |
| Invasive Ductal Breast Carcinoma |
0.4% |
| Myocardial Infarction |
0.4% |
| Oestrogen Receptor Assay Positive |
0.3% |
| Depression |
0.2% |
| Endometrial Cancer |
0.2% |
| Uterine Cancer |
0.1% |
| Transient Ischaemic Attack |
0.1% |
| Weight Increased |
0.1% |
| Lymphoedema |
0.1% |
| Lung Neoplasm Malignant |
0.1% |
|
| Secondary |
| Hormone Replacement Therapy |
65.5% |
| Menopausal Symptoms |
11.1% |
| Menopause |
8.1% |
| Oestrogen Replacement Therapy |
3.2% |
| Hot Flush |
2.1% |
| Hormone Therapy |
1.2% |
| Hypertension |
1.1% |
| Depression |
1.0% |
| Night Sweats |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Vulvovaginal Dryness |
0.8% |
| Osteoporosis |
0.8% |
| Mood Swings |
0.7% |
| Vulvovaginal Pain |
0.6% |
| Osteoporosis Prophylaxis |
0.4% |
| Prophylaxis |
0.4% |
| Hypothyroidism |
0.4% |
| Anxiety |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Diabetes Mellitus |
0.3% |
|
| Breast Cancer |
63.4% |
| Breast Cancer Metastatic |
15.3% |
| Breast Cancer Female |
9.5% |
| Breast Cancer In Situ |
1.4% |
| Progesterone Receptor Assay Positive |
1.4% |
| Contralateral Breast Cancer |
1.3% |
| Breast Cancer Recurrent |
1.3% |
| Ovarian Cancer |
1.2% |
| Thrombosis |
0.7% |
| Ovarian Cancer Metastatic |
0.7% |
| Cerebrovascular Accident |
0.7% |
| Pulmonary Embolism |
0.5% |
| Deep Vein Thrombosis |
0.5% |
| Uterine Leiomyoma |
0.4% |
| Weight Increased |
0.4% |
| Weight Decreased |
0.3% |
| Myocardial Infarction |
0.3% |
| Scar |
0.3% |
| Metastases To Lymph Nodes |
0.3% |
| Pain |
0.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.3% |
| Drug Use For Unknown Indication |
9.1% |
| Hormone Replacement Therapy |
8.9% |
| Osteoporosis |
8.5% |
| Osteopenia |
7.3% |
| Pain |
5.6% |
| Hypertension |
5.1% |
| Depression |
4.9% |
| Asthma |
3.5% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Breast Cancer |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Multiple Myeloma |
2.4% |
| Contraception |
2.4% |
| Hypothyroidism |
2.4% |
| Menopause |
2.4% |
| Breast Cancer Metastatic |
2.3% |
| Anxiety |
2.0% |
| Prophylaxis |
2.0% |
| Migraine |
1.9% |
|
| Pulmonary Embolism |
9.7% |
| Vomiting |
9.4% |
| Weight Increased |
9.4% |
| Weight Decreased |
8.0% |
| Visual Acuity Reduced |
7.3% |
| Deep Vein Thrombosis |
6.8% |
| Pain |
6.5% |
| Breast Cancer |
6.1% |
| Vaginal Haemorrhage |
4.8% |
| Thrombosis |
3.6% |
| Vision Blurred |
3.6% |
| Urinary Tract Infection |
3.4% |
| Nausea |
3.1% |
| Drug Ineffective |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Pneumonia |
2.7% |
| Rash |
2.4% |
| Somnolence |
2.4% |
| Transient Ischaemic Attack |
2.4% |
| White Blood Cell Count Decreased |
2.4% |
|
| Interacting |
| Epilepsy |
35.3% |
| Menopause |
23.5% |
| Depression |
11.8% |
| Hormone Level Abnormal |
11.8% |
| Hypertension |
5.9% |
| Menopausal Symptoms |
5.9% |
| Smear Cervix Abnormal |
5.9% |
|
| Epilepsy |
33.3% |
| Somnolence |
33.3% |
| Squamous Cell Carcinoma Of Skin |
33.3% |
|
